Advertisement

Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention in Patients With Renal Dysfunction

Published:January 07, 2020DOI:https://doi.org/10.1016/j.amjcard.2019.12.045
      Although contemporary chronic total occlusion (CTO) percutaneous coronary intervention (PCI) is performed with high success rates, 10% to 13% of patients presenting with CTOs have chronic kidney disease (CKD), and the comparative safety, efficacy, and health status benefit of CTO PCI in these patients, has not been well defined. We examined the association of baseline renal function with periprocedural major adverse cardiovascular and cerebral events and health status outcomes in 957 consecutive patients (mean age 65.3 ± 10.3 years, 19.4% women, 90.3% white, 23.6 CKD [estimated glomerular filtration rate {eGFR} < 60]) in the OPEN-CTO (Outcomes, Patients Health Status, and Efficiency in Chronic Total Occlusions Registry) study. Hierarchical multivariable regression models were used to examine the independent association of baseline eGFR with technical success, periprocedural complications and change in health status, using Seattle Angina Questionnaire (SAQ) over 1 year. Crude rates of acute kidney injury were higher (13.5% vs 4.4%, p <0.001) and technical success lower (81.8% vs 88.4%, p = 0.01) in patients with CKD. There were no significant differences in other periprocedural complications. After adjustment for confounding factors, there was no significant association of baseline eGFR with technical success or periprocedural major adverse cardiovascular and cerebral events (death, myocardial infarction, emergent bypass surgery, stroke, perforation), whereas patients with lower eGFR had higher rates of acute kidney injury. The difference in SAQ summary score, between patients on the 10th and 90th percentile for baseline eGFR distribution was not clinically significant (1 month: −0.91; 1 year: −3.06 points). In conclusion, CTO PCI success, complication rates, and the health status improvement after CTO PCI are similar in patients across a range of baseline eGFRs.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Rossello X
        • Pujadas S
        • Serra A
        • Bajo E
        • Carreras F
        • Barros A
        • Cinca J
        • Pons-Llado G
        • Vaquerizo B
        Assessment of inducible myocardial ischemia, quality of life, and functional status after successful percutaneous revascularization in patients with chronic total coronary occlusion.
        Am J Cardiol. 2016; 117: 720-726
        • Pujadas S
        • Martin V
        • Rossello X
        • Carreras F
        • Barros A
        • Leta R
        • Alomar X
        • Cinca J
        • Sabate M
        • Pons-Llado G
        Improvement of myocardial function and perfusion after successful percutaneous revascularization in patients with chronic total coronary occlusion.
        Int J Cardiol. 2013; 169: 147-152
        • Sapontis J
        • Salisbury AC
        • Yeh RW
        • Cohen DJ
        • Hirai T
        • Lombardi W
        • McCabe JM
        • Karmpaliotis D
        • Moses J
        • Nicholson WJ
        • Pershad A
        • Wyman RM
        • Spaedy A
        • Cook S
        • Doshi P
        • Federici R
        • Thompson CR
        • Marso SP
        • Nugent K
        • Gosch K
        • Spertus JA
        • Grantham JA
        Early procedural and health status outcomes after chronic total occlusion angioplasty: a report from the OPEN-CTO registry (outcomes, patient health status, and efficiency in chronic total occlusion hybrid procedures).
        JACC Cardiovasc Interv. 2017; 10: 1523-1534
        • Gao L
        • Wang Y
        • Liu Y
        • Cao F
        • Chen Y
        Long-term clinical outcomes of successful revascularization with drug-eluting stents for chronic total occlusions: a systematic review and meta-analysis.
        Catheter Cardiovasc Interv. 2017; 89: 574-581
        • George S
        • Cockburn J
        • Clayton TC
        • Ludman P
        • Cotton J
        • Spratt J
        • Redwood S
        • de Belder M
        • de Belder A
        • Hill J
        • Hoye A
        • Palmer N
        • Rathore S
        • Gershlick A
        • Di Mario C
        • Hildick-Smith D
        Long-term follow-up of elective chronic total coronary occlusion angioplasty: analysis from the U.K. Central Cardiac Audit Database.
        J Am Coll Cardiol. 2014; 64: 235-243
        • Tomasello SD
        • Boukhris M
        • Giubilato S
        • Marza F
        • Garbo R
        • Contegiacomo G
        • Marzocchi A
        • Niccoli G
        • Gagnor A
        • Varbella F
        • Desideri A
        • Rubartelli P
        • Cioppa A
        • Baralis G
        • Galassi AR
        Management strategies in patients affected by chronic total occlusions: results from the Italian Registry of Chronic Total Occlusions.
        Eur Heart J. 2015; 36: 3189-3198
        • Naganuma T
        • Tsujita K
        • Mitomo S
        • Ishiguro H
        • Basavarajaiah S
        • Sato K
        • Kobayashi T
        • Obata J
        • Nagamatsu S
        • Yamanaga K
        • Komura N
        • Sakamoto K
        • Yamamoto E
        • Izumiya Y
        • Kojima S
        • Kaikita K
        • Ogawa H
        • Nakamura S
        Impact of chronic kidney disease on outcomes after percutaneous coronary intervention for chronic total occlusions (from the Japanese Multicenter Registry).
        Am J Cardiol. 2018; 121: 1519-1523
        • Stahli BE
        • Gebhard C
        • Gick M
        • Ferenc M
        • Mashayekhi K
        • Buettner HJ
        • Neumann FJ
        • Toma A
        Outcomes after percutaneous coronary intervention for chronic total occlusion according to baseline renal function.
        Clin Res Cardiol. 2018; 107: 259-267
        • Zhang QB
        • Chen LM
        • Li M
        • Cui YQ
        • Zhao CY
        • Cui LQ
        Influence of chronic kidney disease on the outcome of patients with chronic total occlusion.
        Am J Transl Res. 2016; 8: 196-208
        • Sapontis J
        • Marso SP
        • Cohen DJ
        • Lombardi W
        • Karmpaliotis D
        • Moses J
        • Nicholson WJ
        • Pershad A
        • Wyman RM
        • Spaedy A
        • Cook S
        • Doshi P
        • Federici R
        • Thompson CR
        • Nugent K
        • Gosch K
        • Spertus JA
        • Grantham JA
        The outcomes, patient health status, and efficiency in chronic total occlusion hybrid procedures registry: rationale and design.
        Coron Artery Dis. 2017; 28: 110-119
        • Brilakis ES
        • Grantham JA
        • Rinfret S
        • Wyman RM
        • Burke MN
        • Karmpaliotis D
        • Lembo N
        • Pershad A
        • Kandzari DE
        • Buller CE
        • DeMartini T
        • Lombardi WL
        • Thompson CA
        A percutaneous treatment algorithm for crossing coronary chronic total occlusions.
        JACC Cardiovasc Interv. 2012; 5: 367-379
        • Levey AS
        • Coresh J
        • Greene T
        • Stevens LA
        • Zhang YL
        • Hendriksen S
        • Kusek JW
        • Van Lente F
        Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate.
        Ann Intern Med. 2006; 145: 247-254
        • Webster AC
        • Nagler EV
        • Morton RL
        • Masson P
        Chronic kidney disease.
        Lancet. 2017; 389: 1238-1252
        • Thygesen K
        • Alper JS
        • Jaffe AS
        • Chaitman BR
        • Bax JJ
        • Morrow DA
        • White HD
        Fourth universal definition of myocardial infarction (2018).
        J Am Coll Cardiol. 2018; 72: 2231-2264
        • Ellis SG
        • Ajluni S
        • Arnold AZ
        • Popma JJ
        • Bittl JA
        • Eigler NL
        • Cowley MJ
        • Raymond RE
        • Safian RD
        • Whitlow PL
        Increased coronary perforation in the new device era. Incidence, classification, management, and outcome.
        Circulation. 1994; 90: 2725-2730
        • Mehta RL
        • Kellum JA
        • Shah SV
        • Molitoris BA
        • Ronco C
        • Warnock DG
        • Levin A
        Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury.
        Crit Care. 2007; 11: R31
        • Spertus JA
        • Winder JA
        • Dewhurst TA
        • Deyo RA
        • Fihn SD
        Monitoring the quality of life in patients with coronary artery disease.
        Am J Cardiol. 1994; 74: 1240-1244
        • Spertus JA
        • Winder JA
        • Dewhurst TA
        • Deyo RA
        • Prodzinski J
        • McDonell M
        • Fihn SD
        Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease.
        J Am Coll Cardiol. 1995; 25: 333-341
        • Chan PS
        • Jones PG
        • Arnold SA
        • Spertus JA
        Development and validation of a short version of the Seattle Angina Questionnaire.
        Circ Cardiovasc Qual Outcomes. 2014; 7: 640-647
        • Wyrwich KW
        • Spertus JA
        • Kroenke K
        • Tierney WM
        • Babu AN
        • Wolinsky FD
        Clinically important differences in health status for patients with heart disease: an expert consensus panel report.
        Am Heart J. 2004; 147: 615-622
        • Qintar M
        • Grantham JA
        • Sapontis J
        • Gosch KL
        • Lombardi W
        • Karmpaliotis D
        • Moses J
        • Salisbury AC
        • Cohen DJ
        • Spertus JA
        • Arnold SV
        Dyspnea among patients with chronic total occlusions undergoing percutaneous coronary intervention: prevalence and predictors of improvement.
        Circ Cardiovasc Qual Outcomes. 2017; 10e003665
        • Rose GA
        • Blackburn H
        Cardiovascular survey methods.
        Monogr Ser World Health Organ. 1968; 56: 1-188
        • Arnold SV
        • Spertus JA
        • Jones PG
        • Xiao L
        • Cohen DJ
        The impact of dyspnea on health-related quality of life in patients with coronary artery disease: results from the PREMIER registry.
        Am Heart J. 2009; 157 (e1041): 1042-1049
        • Salisbury AC
        • Sapontis J
        • Grantham JA
        • Qintar M
        • Gosch KL
        • Lombardi W
        • Karmpaliotis D
        • Moses J
        • Cohen DJ
        • Spertus JA
        • Kosiborod M
        Outcomes of chronic total occlusion percutaneous coronary intervention in patients with diabetes: insights from the OPEN CTO registry.
        JACC Cardiovasc Interv. 2017; 10: 2174-2181
        • Yamamoto E
        • Natsuaki M
        • Morimoto T
        • Furukawa Y
        • Nakagawa Y
        • Ono K
        • Mitsudo K
        • Nobuyoshi M
        • Doi O
        • Tamura T
        • Tanaka M
        • Kimura T
        Long-term outcomes after percutaneous coronary intervention for chronic total occlusion (from the CREDO-Kyoto registry cohort-2).
        Am J Cardiol. 2013; 112: 767-774
        • Shimura T
        • Yamamoto M
        • Tsuchikane E
        • Teramoto T
        • Kimura M
        • Matsuo H
        • Kawase Y
        • Suzuki Y
        • Kano S
        • Habara M
        • Nasu K
        • Kinoshita Y
        • Terashima M
        • Matsubara T
        • Suzuki T
        Rates of future hemodialysis risk and beneficial outcomes for patients with chronic kidney disease undergoing recanalization of chronic total occlusion.
        Int J Cardiol. 2016; 222: 707-713
        • Azzalini L
        • Ojeda S
        • Karatasakis A
        • Maeremans J
        • Tanabe M
        • La Manna A
        • Dautov R
        • Ybarra LF
        • Benincasa S
        • Bellini B
        • Candilio L
        • Demir OM
        • Hidalgo F
        • Karacsonyi J
        • Gravina G
        • Micciche E
        • D'Agosta G
        • Venuti G
        • Tamburino C
        • Pan M
        • Carlino M
        • Dens J
        • Brilakis ES
        • Colombo A
        • Rinfret S
        Long-term outcomes of percutaneous coronary intervention for chronic total occlusion in patients who have undergone coronary artery bypass grafting vs those who have not.
        Can J Cardiol. 2018; 34: 310-318
        • Aguiar-Souto P
        • Ferrante G
        • Del Furia F
        • Barlis P
        • Khurana R
        • Di Mario C
        Frequency and predictors of contrast-induced nephropathy after angioplasty for chronic total occlusions.
        Int J Cardiol. 2010; 139: 68-74
        • Lin YS
        • Fang HY
        • Hussein H
        • Fang CY
        • Chen YL
        • Hsueh SK
        • Cheng CI
        • Yang CH
        • Chen CJ
        • Hang CL
        • Yip HK
        • Wu CJ
        Predictors of contrast-induced nephropathy in chronic total occlusion percutaneous coronary intervention.
        EuroIntervention. 2014; 9: 1173-1180
        • Odden MC
        • Whooley MA
        • Shlipak MG
        Association of chronic kidney disease and anemia with physical capacity: the heart and soul study.
        J Am Soc Nephrol. 2004; 15: 2908-2915